Gastón Soria, as Co-Founder and Chief Scientific Officer at OncoPrecision, is at the forefront of revolutionizing cancer treatment through innovative scientific methodologies. His leadership in developing a cutting-edge phenotypic screening engine leverages patient-derived cells to predict clinical outcomes, a critical advancement in the realm of...
Gastón Soria, as Co-Founder and Chief Scientific Officer at OncoPrecision, is at the forefront of revolutionizing cancer treatment through innovative scientific methodologies. His leadership in developing a cutting-edge phenotypic screening engine leverages patient-derived cells to predict clinical outcomes, a critical advancement in the realm of precision medicine. By integrating neoplastic and normal cells from both autologous and heterologous origins, Gastón and his team are able to dissect the complexities of drug selectivity and unspecific toxicity, ultimately enhancing therapeutic efficacy for cancer patients.
Under his guidance, OncoPrecision is pioneering high-throughput functional assays that utilize patient-derived cancer cells. These assays serve as a vital tool for personalized therapy selection, providing oncologists with a comprehensive matrix of available prescription drugs tailored to the unique genetic and epigenetic profiles of individual tumors. Gastón’s expertise in molecular biology, combined with advanced techniques such as confocal and two-photon microscopy, enables the team to explore intricate cellular interactions and DNA repair mechanisms, which are essential for understanding treatment responses.
Moreover, his skills in negotiation and development strategy have been instrumental in fostering collaborations with research institutions and pharmaceutical companies, further propelling OncoPrecision's mission. As the landscape of cancer treatment evolves, Gastón Soria remains committed to bridging the gap between laboratory research and clinical application, ensuring that patients receive the most effective and personalized therapeutic options available.